July 14, 2025 · Form 4 insider transaction
Burnett Patrick sold 5,750 shares of Arcutis Biotherapeutics, Inc. at $15.07 per share, a transaction worth $86.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.; The transaction was executed in multiple trades in prices ranging from $15.00 to $15.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.